News
11-01-2012, 04:11 AM
New research led by the University of Manchester in the UK has found a biomarker or molecular "flag" in women with breast cancer who do not repond, or who have become resistant, to treatment with the hormone drug tamoxifen...
More... (http://www.medicalnewstoday.com/articles/252249.php)
More... (http://www.medicalnewstoday.com/articles/252249.php)